Blocking Memories to Treat Alcoholism

Targeting a molecular pathway involved with learning and memory helps rats with a taste for booze wean themselves off of the sauce.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, KEN30684The key to preventing relapse in recovering alcoholics may be to block memories associated with the pleasurable effects of drinking, according to a new study in rats. Neuroscientists at the University of California, San Francisco (UCSF), found that administering the drug rapamycin to block the mTORC1 pathway, which is associated with learning and memory, helped reduce alcoholic relapse in rats that had developed a preference for alcohol. The results were published Sunday (June 23) in Nature Neuroscience.

The mTORC1 pathway is versatile, spawning proteins that regulate a variety of physiological functions in several species, from autophagy and the growth and proliferation of stem cells to mitochondrial metabolism and memory recall. Rapamycin, a powerful antifungal, disrupts the mTORC1 pathway, and research has already shown the drug’s potential in treating drug addiction and post-traumatic stress disorder byu targeting the pathway. “It’s really excellent,” Charles O’Brien, director of the Center for Studies of Addiction at the University of Pennsylvania in Philadelphia, told Nature. “Fundamentally, addiction is a memory, and [the authors] are going straight at what is actually going on in the brain.”

UCSF neuroscientist Dorit Ron, who led the team of researchers, told Nature that while the scientists weren’t sure which specific memory they ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies